沙利度胺叠加DOF方案治疗Ⅳ期胃癌患者的效果及对血清sVEGFR-1、TGF-β1表达的作用

doi:10.3969/j.issn.1674-4985.2023.24.018

中国医学创新

2023, Vol. 20

Issue (24): 77-80 DOI: 10.3969/j.issn.1674-4985.2023.24.018

Clinical research

Current Issue | Archive | Adv Search

Effect of Thalidomide Plus DOF Regimen in the Treatment of Patients with Stage Ⅳ Gastric Cancer and Its Influence on Expression of Serum sVEGFR-1 and TGF-β1

YANG Yanbing

First-author's address: Dandong First Hospital, Liaoning Province, Dandong 118000, China

Abstract
Figure/Table
References
Related Citation (3)